Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study.
Palmerini E, Pazzaglia L, Cevolani L, Pratelli L, Pierini M, Quattrini I, Carretta E, Manara MC, Pasello M, Frega G, Paioli A, Longhi A, Cesari M, Hakim R, Ibrahim T, Campanacci L, Staals EL, Donati DM, Benassi MS, Scotlandi K, Ferrari S.
Palmerini E, et al. Among authors: hakim r.
Cancers (Basel). 2022 Jun 10;14(12):2863. doi: 10.3390/cancers14122863.
Cancers (Basel). 2022.
PMID: 35740530
Free PMC article.